CS logo
small CS logo
Arcispedale Santa Maria Nuova; Oncologia

Reggio Emilia, Emilia-Romagna, Italy
Hospital department in Reggio Emilia
Viale Risorgimento, 57, 42123 Reggio Emilia RE

About Arcispedale Santa Maria Nuova; Oncologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Arcispedale Santa Maria Nuova; Oncologia


During the past decade, Arcispedale Santa Maria Nuova; Oncologia conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Arcispedale Santa Maria Nuova; Oncologia" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

Clinical Trials Conditions at Arcispedale Santa Maria Nuova; Oncologia


According to Clinical.Site data, the most researched conditions in "Arcispedale Santa Maria Nuova; Oncologia" are "Breast Cancer" (3 trials), "Metastatic Colorectal Cancer" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Cancer of Unknown Primary Site" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "Arcispedale Santa Maria Nuova; Oncologia" in a lesser frequency.

Clinical Trials Intervention Types at Arcispedale Santa Maria Nuova; Oncologia


Most popular intervention types in "Arcispedale Santa Maria Nuova; Oncologia" are "Drug" (14 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Paclitaxel" (4 trials), "Bevacizumab" (3 trials), "Carboplatin" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Arcispedale Santa Maria Nuova; Oncologia


The vast majority of trials in "Arcispedale Santa Maria Nuova; Oncologia" are 16 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Arcispedale Santa Maria Nuova; Oncologia


Currently, there are NaN active trials in "Arcispedale Santa Maria Nuova; Oncologia". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Arcispedale Santa Maria Nuova; Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Arcispedale Santa Maria Nuova; Oncologia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".